| Metabolic profiling uncovers a phenotypic signature of small for gestational age in early pregnancy RP Horgan, DI Broadhurst, SK Walsh, WB Dunn, M Brown, CT Roberts, ... Journal of proteome research 10 (8), 3660-3673, 2011 | 136 | 2011 |
| Animal models of preeclampsia; uses and limitations FP McCarthy, JC Kingdom, LC Kenny, SK Walsh Placenta 32 (6), 413-419, 2011 | 136 | 2011 |
| Evidence implicating peroxisome proliferator-activated receptor-γ in the pathogenesis of preeclampsia FP McCarthy, S Drewlo, FA English, J Kingdom, EJ Johns, LC Kenny, ... Hypertension 58 (5), 882-887, 2011 | 115 | 2011 |
| Acute administration of cannabidiol in vivo suppresses ischaemia‐induced cardiac arrhythmias and reduces infarct size when given at reperfusion SK Walsh, CY Hepburn, KA Kane, CL Wainwright British journal of pharmacology 160 (5), 1234-1242, 2010 | 99 | 2010 |
| Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization SK Walsh, FA English, EJ Johns, LC Kenny Hypertension 54 (2), 345-351, 2009 | 89 | 2009 |
| Peroxisome proliferator-activated receptor-γ as a potential therapeutic target in the treatment of preeclampsia FP McCarthy, S Drewlo, J Kingdom, EJ Johns, SK Walsh, LC Kenny Hypertension 58 (2), 280-286, 2011 | 81 | 2011 |
| GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues C Lipina, SK Walsh, SE Mitchell, JR Speakman, CL Wainwright, ... FASEB Journal, 2018 | 59 | 2018 |
| PPAR‐γ–a possible drug target for complicated pregnancies FP McCarthy, AC Delany, LC Kenny, SK Walsh British journal of pharmacology 168 (5), 1074-1085, 2013 | 52 | 2013 |
| Pharmacological profiling of the haemodynamic effects of cannabinoid ligands: A combined in vitro and in vivo approach. SK Walsh, CY Hepburn, O Keown, A Astrand, A Lindblom, E Ryberg, ... Pharmacology Research & Perspectives 3 (3), 2015 | 28 | 2015 |
| l‐α‐Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK‐dependent pathway OJ Robertson‐Gray, SK Walsh, E Ryberg, A-C Jönsson‐Rylander, C Lipina, CL ... Pharmacology Research & Perspectives 7 (3), e00487, 2019 | 25 | 2019 |
| GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired adrenoceptor-mediated inotropic responses SK Walsh, EE Hector, AC Andreasson, AC Jönsson-Rylander, ... PloS one 9 (10), e108999, 2014 | 25 | 2014 |
| Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre‐eclampsia SK Walsh, FA English, IP Crocker, EJ Johns, LC Kenny British journal of pharmacology 166 (7), 2109-2116, 2012 | 19 | 2012 |
| Mast cell degranulation–a mechanism for the anti‐arrhythmic effect of endothelin‐1? SK Walsh, KA Kane, CL Wainwright British journal of pharmacology 157 (5), 716-723, 2009 | 16 | 2009 |
| Mast cells, peptides and cardioprotection–an unlikely marriage? SK Walsh, KA Kane, CL Wainwright Autonomic and Autacoid Pharmacology 29 (3), 73-84, 2009 | 14 | 2009 |
| Administration of the PARP Inhibitor Pj34 Ameliorates the Impaired Vascular Function Associated With Enos−/− Mice FA English, FP Mccarthy, IJ Andersson, JL Stanley, ST Davidge, PN Baker, ... Reproductive Sciences 19 (8), 806-813, 2012 | 12 | 2012 |
| Acute dietary zinc deficiency in rats exacerbates myocardial ischaemia– reperfusion injury through depletion of glutathione K Skene, SK Walsh, O Okafor, N Godsman, C Barrows, P Meier, MJ Gordon, JH ... British Journal of Nutrition, 1-13, 2019 | 8* | 2019 |
| GPR55 regulates the responsiveness to, but does not dimerise with, α1A-adrenoceptors SK Walsh, C Lipina, SY Ang, M Sato, LY Chia, M Kocan, DS Hutchinson, ... Biochemical Pharmacology 188, 114560, 2021 | | 2021 |
Louise KennyExecutive Pro Vice Chancellor, Faculty of Health and Life Sciences, University of LiverpoolVerified email at liverpool.ac.uk
